Refractory neuro-Sweet disease successfully treated with tocilizumab and mycophenolate mofetil
encephalitis · 2020
DOI: 10.47936/encephalitis.2020.00059 ↗Kurz gefasst
Fallbericht in der Zeitschrift encephalitis, 2020. Verfasst von Sungeun Hwang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Seoul National University Hospital, Seoul, Korea. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Seoul National University Hospital, Seoul, Korea.
- Laboratory for Neurotherapeutics, Center for Medical Innovations, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.
- Rare Disease Center, Seoul National University Hospital, Seoul, Korea.
- Department of Neurology, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea.
ORCID-Profile: Kon Chu
Zitieren
APA
Hwang, S., Son, H., Moon, J., Lee, S. T., Jung, K. H., Park, K. I., Lee, S. K., & Chu, K. (2020). Refractory neuro-Sweet disease successfully treated with tocilizumab and mycophenolate mofetil. encephalitis. https://doi.org/10.47936/encephalitis.2020.00059
Vancouver
Hwang S, Son H, Moon J, Lee ST, Jung KH, Park KI, et al. Refractory neuro-Sweet disease successfully treated with tocilizumab and mycophenolate mofetil. encephalitis. 2020. doi:10.47936/encephalitis.2020.00059
BibTeX
@article{Hwang2020,
author = {Hwang, Sungeun and Son, Hyoshin and Moon, Jangsup and Lee, Soon-Tae and Jung, Keun Hwa and Park, Kyung-Il and Lee, Sang Kun and Chu, Kon},
title = {Refractory neuro-Sweet disease successfully treated with tocilizumab and mycophenolate mofetil},
journal = {encephalitis},
year = {2020},
doi = {10.47936/encephalitis.2020.00059}
}
EUVIMED